Trials / Completed
CompletedNCT02918721
Pain and Safety of Restylane With and Without Lidocaine for Correction of Moderate and Severe Nasolabial Folds
A Randomised, Multi-center, Subject and Evaluator-blinded Study Comparing Pain and Safety Profile Associated With Correction of Moderate to Severe Nasolabial Folds Using Restylane With and Without Addition of 0.3% Lidocaine Hydrochloride
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 70 (actual)
- Sponsor
- Galderma R&D · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to evaluate the pain and safety associated with injections of Restylane Lidocaine compared to Restylane using a visual analogue scale.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Restylane Lidocaine | Intradermal injection |
| DEVICE | Restylane | Intradermal injection |
Timeline
- Start date
- 2017-02-08
- Primary completion
- 2017-04-27
- Completion
- 2017-05-11
- First posted
- 2016-09-29
- Last updated
- 2023-06-01
- Results posted
- 2021-01-06
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT02918721. Inclusion in this directory is not an endorsement.